MicroRNAs as important players and biomarkers in oral carcinogenesis

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Min, Anjie ^a   Zhu, Chao ^a,b   Peng, Shuping ^b   Rajthala, Saroj ^c   Costea, Daniela Elena ^c,d   Sapkota, Dipak ^c,d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF BERGEN   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER PROGNOSIS; CARCINOGENESIS; GENE TARGETING; HUMAN; MOLECULAR PATHOLOGY; MOUTH SQUAMOUS CELL CARCINOMA; REVIEW; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE; ANIMAL; CARCINOMA, SQUAMOUS CELL; EVIDENCE BASED MEDICINE; HEAD AND NECK NEOPLASMS; METABOLISM; MOUTH TUMOR; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ANIMALS; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; EVIDENCE-BASED MEDICINE; HEAD AND NECK NEOPLASMS; HUMANS; MICRORNAS; MOUTH NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84945323017     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/186904     Document Type: Review

References (99)

1. J. Ferlay, I. Soerjomataram, R. Dikshit et al., "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012," International Journal of Cancer, vol. 136, no. 5, pp. E359-E386, 2015.
2. R. Siegel, D. Naishadham, and A. Jemal, "Cancer statistics, 2013," CA Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11-30, 2013.
3. J. Massano, F. S. Regateiro, G. Januaŕio, and A. Ferreira, "Oral squamous cell carcinoma: review of prognostic and predictive factors," Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 102, no. 1, pp. 67-76, 2006.
4. K. D. C. B. Ribeiro, L. P. Kowalski, and M. D. R. D. D. O. Latorre, "Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer," Archives of Otolaryngology- Head & Neck Surgery, vol. 129, no. 2, pp. 219-228, 2003.
5. T. Hunter, "Cooperation between oncogenes," Cell, vol. 64, no. 2, pp. 249-270, 1991.
6. J. M. Bishop, "Molecular themes in oncogenesis," Cell, vol. 64, no. 2, pp. 235-248, 1991.
7. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function," Cell, vol. 116, no. 2, pp. 281-297, 2004.
8. V. Ambros, "The functions of animal microRNAs," Nature, vol. 431, no. 7006, pp. 350-355, 2004.
9. A. E. Pasquinelli, S. Hunter, and J. Bracht, "MicroRNAs: a developing story," Current Opinion in Genetics and Development, vol. 15, no. 2, pp. 200-205, 2005.
10. L. P. Lim, N. C. Lau, P. Garrett-Engele et al., "Microarray analysis shows that some microRNAs downregulate large numbers of-target mRNAs," Nature, vol. 433, no. 7027, pp. 769-773, 2005.
11. B. D. Harfe, "MicroRNAs in vertebrate development," Current Opinion in Genetics & Development, vol. 15, no. 4, pp. 410-415, 2005.
12. D. P. Bartel and C.-Z. Chen, "Micromanagers of gene expression: the potentially widespread infuence of metazoan microR-NAs," Nature Reviews Genetics, vol. 5, no. 5, pp. 396-400, 2004.
13. N. Rajewsky, "microRNA target predictions in animals," Nature Genetics, vol. 38, pp. S8-S13, 2006.
14. N. Tran, C. J. O'Brien, J. Clark, and B. Rose, "Potential role of micro-RNAs in head and neck tumorigenesis," Head & Neck, vol. 32, no. 8, pp. 1099-1111, 2010.
15. N. Sethi, A. Wright, H. Wood, and P. Rabbitts, "MicroRNAs and head and neck cancer: reviewing the frst decade of research," European Journal of Cancer, vol. 50, no. 15, pp. 2619-2635, 2014.
16. J. Li, H. Huang, L. Sun et al., "MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor," Clinical Cancer Research, vol. 15, no. 12, pp. 3998-4008, 2009.
17. M. Avissar, B. C. Christensen, K. T. Kelsey, and C. J. Marsit, "MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma," Clinical Cancer Research, vol. 15, no. 8, pp. 2850-2855, 2009.
18. A. Kawakita, S. Yanamoto, S.-I. Yamada et al., "MicroRNA-21 promotes oral cancer invasion via the wnt/κ-catenin pathway by targeting DKK2," Pathology & Oncology Research, vol. 20, no. 2, pp. 253-261, 2014.
19. D. Chen, R. J. Cabay, Y. Jin et al., "MicroRNA deregulations in head and neck squamous cell carcinomas," Journal of Oral & Maxillofacial Research, vol. 4, no. 1, article e2, 2013.
20. N. Hedbäck, D. H. Jensen, L. Specht et al., "miR-21 expression in the tumor stroma of oral squamous cell carcinoma: an independent biomarker of disease free survival," PLoS ONE, vol. 9, no. 4, Article ID e95193, 2014.
21. J. A. R. Brito, C. C. Gomes, A. L. S. Guimarães, K. Campos, and R. S. Gomez, "Relationship between microRNA expression levels and histopathological features of dysplasia in oral leuko-plakia," Journal of Oral Pathology and Medicine, vol. 43, no. 3, pp. 211-216, 2014.
22. W. Mydlarz, M. Uemura, S. Ahn et al., "Clusterin is a gene-specifc target of microRNA-21 in head and neck squamous cell carcinoma," Clinical Cancer Research, vol. 20, no. 4, pp. 868-877, 2014.
23. P. P. Reis, M. Tomenson, N. K. Cervigne et al., "Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma," Molecular Cancer, vol. 9, article 238, 2010.
24. L. Y. W. Bourguignon, C. Earle, G. Wong, C. C. Spevak, and K. Krueger, "Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells," Oncogene, vol. 31, no. 2, pp. 149-160, 2012.
25. F. Meng, R. Henson, H. Wehbe-Janek, K. Ghoshal, S. T. Jacob, and T. Patel, "MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer," Gastroenterology, vol. 133, no. 2, pp. 647-658, 2007.
26. H. M. Jung, B. L. Phillips, R. S. Patel et al., "Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer," The Journal of Biological Chemistry, vol. 287, no. 35, pp. 29261-29272, 2012.
27. Q. Li, D. Zhang, Y. Wang et al., "MiR-21/Smad 7 signaling determines TGF-κ1-induced CAF formation," Scientifc Reports, vol. 3, article 2038, 2013.
28. C.-J. Liu, M.-M. Tsai, P.-S. Hung et al., "miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma," Cancer Research, vol. 70, no. 4, pp. 1635-1644, 2010.
29. ∗ is negatively associated with recurrent/newly formed oral leukoplakia," PLoS ONE, vol. 7, no. 6, Article ID e38648, 2012.
30. S.-B. Ouyang, J. Wang, Z.-K. Huang, and L. Liao, "Expression of microRNA-31 and its clinicopathologic signifcance in oral squamous cell carcinoma," Zhonghua Kou Qiang Yi Xue Za Zhi, vol. 48, no. 8, pp. 481-484, 2013.
31. P.-S. Hung, H.-F. Tu, S.-Y. Kao et al., "miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes," Carcinogenesis, vol. 35, no. 5, pp. 1162-1171, 2014.
32. K.-W. Chang, S.-Y. Kao, Y.-H. Wu et al., "Passenger strand miRNA miR-31 regulates the phenotypes of oral cancer cells by targeting RhoA," Oral Oncology, vol. 49, no. 1, pp. 27-33, 2013.
33. P.-S. Hung, C.-J. Liu, C.-S. Chou et al., "miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes," PLoS ONE, vol. 8, no. 11, Article ID e79926, 2013.
34. P.-S. Hung, K.-W. Chang, S.-Y. Kao, T.-H. Chu, C.-J. Liu, and S.-C. Lin, "Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression," Oral Oncology, vol. 48, no. 5, pp. 404-408, 2012.
35. A. Palmieri, F. Carinci, M. Martinelli et al., "Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma," European Journal of Oral Sciences, vol. 122, no. 3, pp. 198-201, 2014.
36. C.-J. Liu, W. G. Shen, S.-Y. Peng et al., "MiR-134 induces onco-genicity and metastasis in head and neck carcinoma through targeting WWOX gene," International Journal of Cancer, vol. 134, no. 4, pp. 811-821, 2014.
37. Y.-H. Ni, X.-F. Huang, Z.-Y. Wang et al., "Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma," Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 117, no. 2, pp. 227-233, 2014.
38. L. J. Shi, C. Y. Zhang, Z. T. Zhou et al., "MicroRNA-155 in oral squamous cell carcinoma: overexpression, localization, and prognostic potential," Head & Neck, 2014.
39. M. I. Rather, M. N. Nagashri, S. S. Swamy, K. S. Gopinath, and A. Kumar, "Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics," Journal of Biological Chemistry, vol. 288, no. 1, pp. 608-618, 2013.
40. T. Venkatesh, M. N. Nagashri, S. S. Swamy, S. M. A. Mohiyud-din, K. S. Gopinath, and A. Kumar, "Primary microcephaly gene MCPH1 shows signatures of tumor suppressors and is regulated by miR-27a in oral squamous cell carcinoma," PLoS ONE, vol. 8, no. 3, Article ID e54643, 2013.
41. Y.-Y. Wu, Y.-L. Chen, Y.-C. Jao, I.-S. Hsieh, K.-C. Chang, and T.-M. Hong, "MiR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1," Angiogenesis, vol. 17, no. 1, pp. 247-260, 2014.
42. B. Kefas, J. Godlewski, L. Comeau et al., "microRNA-7 inhibits the epidermal growth factor receptor and the akt pathway and is down-regulated in glioblastoma," Cancer Research, vol. 68, no. 10, pp. 3566-3572, 2008.
43. S. D. N. Reddy, K. Ohshiro, S. K. Rayala, and R. Kumar, "MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions," Cancer Research, vol. 68, no. 20, pp. 8195-8200, 2008.
44. R. J. Webster, K. M. Giles, K. J. Price, P. M. Zhang, J. S. Mattick, and P. J. Leedman, "Regulation of epidermal growth factor receptor signaling in human cancer cells by MicroRNA-7," The Journal of Biological Chemistry, vol. 284, no. 9, pp. 5731-5741, 2009.
45. L. Jiang, X. Liu, Z. Chen et al., "MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells," Biochemical Journal, vol. 432, no. 1, pp. 199-205, 2010.
46. Y.-C. Yen, S.-G. Shiah, H.-C. Chu et al., "Reciprocal regulation of MicroRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells," Molecular Cancer, vol. 13, no. 1, article 6, 2014.
47. B. Yan, Q. Fu, L. Lai et al., "Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells," Molecular Medicine Reports, vol. 6, no. 3, pp. 675-681, 2012.
48. A. Uesugi, K.-I. Kozaki, T. Tsuruta et al., "The tumor suppressive microRNA miR-218 targets the mTOR component rictor and inhibits AKT phosphorylation in oral cancer," Cancer Research, vol. 71, no. 17, pp. 5765-5778, 2011.
49. J. Minor, X. Wang, F. Zhang et al., "Methylation of microRNA-9 is a specifc and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas," Oral Oncology, vol. 48, no. 1, pp. 73-78, 2012.
50. T. Yu, K. Liu, Y. Wu et al., "MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/κ-catenin signaling pathway," Oncogene, vol. 33, pp. 5017-5027, 2013.
51. J. P. Teir, "Epithelial-mesenchymal transitions in tumor progression," Nature Reviews Cancer, vol. 2, no. 6, pp. 442-454, 2002.
52. Y. Jin, C. Wang, X. Liu et al., "Molecular characterization of the MicroRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma," The Journal of Biological Chemistry, vol. 286, no. 46, pp. 40104-40109, 2011.
53. X. Liu, C. Wang, Z. Chen et al., "MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines," Biochemical Journal, vol. 440, no. 1, pp. 23-31, 2011.
54. L. Jiang, X. Liu, A. Kolokythas et al., "Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma," International Journal of Cancer, vol. 127, no. 3, pp. 505-512, 2010.
55. 1/2 signaling pathway in head and neck squamous cell carcinoma," Oral Oncology, vol. 50, no. 5, pp. 448-456, 2014.
56. M. Liu, J. Wang, H. Huang, J. Hou, B. Zhang, and A. Wang, "MiR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma," Biochemical and Biophysical Research Communications, vol. 441, no. 2, pp. 364-370, 2013.
57. L. Lu, X. Xue, J. Lan et al., "MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis," Biomedicine and Pharmacotherapy, vol. 68, no. 1, pp. 13-19, 2014.
58. S. Hunt, A. V. Jones, E. E. Hinsley, S. A. Whawell, and D. W. Lambert, "MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1," FEBS Letters, vol. 585, no. 1, pp. 187-192, 2011.
59. W.-C. Huang, S.-H. Chan, T.-H. Jang et al., "MiRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis," Cancer Research, vol. 74, no. 3, pp. 751-764, 2014.
60. C.-C. Chang, Y.-J. Yang, Y.-J. Li et al., "MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma," Oral Oncology, vol. 49, no. 9, pp. 923-931, 2013.
61. H. M. Jung, R. S. Patel, B. L. Phillips et al., "Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions," Molecular Biology of the Cell, vol. 24, no. 11, pp. 1638-1648, 2013.
62. N. Nohata, T. Hanazawa, N. Kikkawa et al., "Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC)," Journal of Human Genetics, vol. 56, no. 8, pp. 595-601, 2011.
63. J. Wang, H. Huang, C. Wang, X. Liu, F. Hu, and M. Liu, "MicroRNA-375 sensitizes tumour necrosis factor-alpha (TNF-κ)-induced apoptosis in head and neck squamous cell carcinoma in vitro," International Journal of Oral and Maxillofacial Surgery, vol. 42, no. 8, pp. 949-955, 2013.
64. B. Kumar, A. Yadav, J. Lang, T. N. Teknos, and P. Kumar, "Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis," PLoS ONE, vol. 7, no. 5, Article ID e37601, 2012.
65. M. Shiiba, K. Shinozuka, K. Saito et al., "MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma," British Journal of Cancer, vol. 108, no. 9, pp. 1817-1821, 2013.
66. L. Gao, W. Ren, S. Chang et al., "Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical signifcance," Onkologie, vol. 36, no. 4, pp. 194-199, 2013.
67. Y. Shao, Y. Qu, S. Dang, B. Yao, and M. Ji, "MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6," Cancer Cell International, vol. 13, no. 1, article 51, 2013.
68. N. J. Park, H. Zhou, D. Elashof et al., "Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection," Clinical Cancer Research, vol. 15, no. 17, pp. 5473-5477, 2009.
69. S. A. MacLellan, J. Lawson, J. Baik, M. Guillaud, C. F. Poh, and C. Garnis, "Diferential expression of miRNAs in the serum of patients with high-risk oral lesions," Cancer Medicine, vol. 1, no. 2, pp. 268-274, 2012.
70. S.-C. Lin, C.-J. Liu, J.-A. Lin, W.-F. Chiang, P.-S. Hung, and K.W. Chang, "miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis," Oral Oncology, vol. 46, no. 3, pp. 204-208, 2010.
71. C.-M. Hsu, P.-M. Lin, Y.-M. Wang, Z.-J. Chen, S.-F. Lin, and M.-Y. Yang, "Circulating miRNA is a novel marker for head and neck squamous cell carcinoma," Tumour Biology, vol. 33, no. 6, pp. 1933-1942, 2012.
72. C.-J. Liu, S.-C. Lin, C.-C. Yang, H.-W. Cheng, and K.-W. Chang, "Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma," Head and Neck, vol. 34, no. 2, pp. 219-224, 2012.
73. F. Momen-Heravi, A. J. Trachtenberg, W. P. Kuo, and Y. S. Cheng, "Genomewide study of salivary microRNAs for detection of oral cancer," Journal of Dental Research, vol. 93, no. 7, supplement, pp. 86S-93S, 2014.
74. W.-Y. Lo, H.-J. Wang, C.-W. Chiu, and S.-F. Chen, "miR-27b-regulated TCTP as a novel plasma biomarker for oral cancer: from quantitative proteomics to post-transcriptional study," Journal of Proteomics, vol. 77, pp. 154-166, 2012.
75. J. Dang, Y.-Q. Bian, J. Y. Sun et al., "MicroRNA-137 promoter methylation in oral lichen planus and oral squamous cell carcinoma," Journal of Oral Pathology & Medicine, vol. 42, no. 4, pp. 315-321, 2013.
76. Y. Yang, Y.-X. Li, X. Yang, L. Jiang, Z.-J. Zhou, and Y.-Q. Zhu, "Progress risk assessment of oral premalignant lesions with saliva miRNA analysis," BMC Cancer, vol. 13, article 129, 2013.
77. C.-C. Yang, P.-S. Hung, P.-W. Wang et al., "miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma," Journal of Oral Pathology and Medicine, vol. 40, no. 5, pp. 397-404, 2011.
78. T. Harris, L. Jimenez, N. Kawachi et al., "Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas," The American Journal of Pathology, vol. 180, no. 3, pp. 917-928, 2012.
79. G. Childs, M. Fazzari, G. Kung et al., "Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma," The American Journal of Pathology, vol. 174, no. 3, pp. 736-745, 2009.
80. M. Avissar, M. D. McClean, K. T. Kelsey, and C. J. Marsit, "MicroRNA expression in head and neck cancer associates with alcohol consumption and survival," Carcinogenesis, vol. 30, no. 12, pp. 2059-2063, 2009.
81. M. S. Ebert, J. R. Neilson, and P. A. Sharp, "MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells," Nature Methods, vol. 4, no. 9, pp. 721-726, 2007.
82. R. Garzon, G. Marcucci, and C. M. Croce, "Targeting microR-NAs in cancer: rationale, strategies and challenges," Nature Reviews Drug Discovery, vol. 9, no. 10, pp. 775-789, 2010.
83. E. van Rooij and E. N. Olson, "MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles," Nature Reviews Drug Discovery, vol. 11, no. 11, pp. 860-872, 2012.
84. Y. Dai, C.-H. Xie, J. P. Neis, C.-Y. Fan, E. Vural, and P. M. Spring, "MicroRNA expression profles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance," Head and Neck, vol. 33, no. 6, pp. 786-791, 2011.
85. L. Sun, Y. Yao, B. Liu et al., "MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1," Oncogene, vol. 31, no. 4, pp. 432-445, 2012.
86. Y.-E. Suh, N. Raulf, J. Gäken et al., "microRNA-196a promotes an oncogenic efect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance," International Journal of Cancer, 2015.
87. W. Ren, X. Wang, L. Gao et al., "MiR-21 modulates chemosensi-tivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4," Molecular and Cellular Biochemistry, vol. 390, no. 1-2, pp. 253-262, 2014.
88. L. Piao, M. Zhang, J. Datta et al., "Lipid-based nanoparticle delivery of pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma," Molecular Terapy, vol. 20, no. 6, pp. 1261-1269, 2012.
89. K. Lefort, Y. Brooks, P. Ostano et al., "A miR-34a-SIRT6 axis in the squamous cell diferentiation network," The EMBO Journal, vol. 32, no. 16, pp. 2248-2263, 2013.
90. Y. Kai, W. Peng, W. Ling, H. Jiebing, and B. Zhuan, "Reciprocal efects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells," Biochemical and Biophysical Research Communications, vol. 448, no. 3, pp. 308-314, 2014.
91. K.-H. Shin, S. D. Bae, H. S. Hong, R. H. Kim, M. K. Kang, and N.-H. Park, "miR-181a shows tumor suppressive efect against oral squamous cell carcinoma cells by downregulating K-ras," Biochemical and Biophysical Research Communications, vol. 404, no. 4, pp. 896-902, 2011.
92. J.-S. Kim, S.-K. Yu, M.-H. Lee et al., "MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells," Molecules and Cells, vol. 35, no. 1, pp. 17-24, 2013.
93. J.-S. Kim, S.-Y. Park, S. A. Lee et al., "MicroRNA-205 suppresses the oral carcinoma oncogenic activity via down-regulation of Axin-2 in KB human oral cancer cell," Molecular and Cellular Biochemistry, vol. 387, no. 1-2, pp. 71-79, 2014.
94. T. Bertero, I. Bourget-Ponzio, A. Puissant et al., "Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties," Cell Cycle, vol. 12, no. 14, pp. 2183-2193, 2013.
95. L. Darda, F. Hakami, R. Morgan et al., "The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma," PLOS ONE, vol. 10, no. 4, Article ID e0122285, 2015.
96. I. Fukumoto, T. Hanazawa, T. Kinoshita et al., "MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways," British Journal of Cancer, vol. 112, no. 5, pp. 891-900, 2015.
97. F. Ganci, A. Sacconi, V. Manciocco et al., "microRNAs expression predicts local recurrence risk in oral squamous cell carcinoma," Head & Neck, 2014.
98. C.-J. Liu, M.-M. Tsai, H.-F. Tu, M.-T. Lui, H.-W. Cheng, and S.-C. Lin, "MiR-196a overexpression and mir-196a2 gene polymorphism are prognostic predictors of oral carcinomas," Annals of Surgical Oncology, vol. 20, no. 3, pp. S406-S414, 2013.
99. K.-W. Chang, C.-J. Liu, T.-H. Chu et al., "Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma," Journal of Dental Research, vol. 87, no. 11, pp. 1063-1068, 2008.